Dipyridamole
Back to searchMolecule Structure
Scientific Name
Dipyridamole
Description of the Drug
Dipyridamole is a phosphodiesterase inhibitor used to prevent postoperative thromboembolic events.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00975
http://www.drugbank.ca/drugs/DB00975
Brand Name(s)
Attia, Cerebrovase 100, Cerebrovase 25, Dipyridamole, Iv persantine, Modaplate, Ofcram pr, Persantin, Persantine, Persantin ret, Pyridantin, Vasyrol
Company Owner(s)
Glenmark Generics Inc Usa, Watson Laboratories Inc, Genus Lifesciences Inc, Purepac Pharmaceutical Co, Amneal Pharmaceuticals Of New York Llc, Hospira Worldwide, Inc, Zydus Pharmaceuticals Usa Inc, Impax Laboratories Inc, Micro Labs Ltd, Fresenius Kabi Usa Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| 3′,5′-cyclic phosphodiesterase | PROTEIN FAMILY | INHIBITOR | CHEMBL2363066 |
| Equilibrative nucleoside transporter 1 | SINGLE PROTEIN | INHIBITOR | CHEMBL1997 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL16119 | |||||||
| PharmGKB | PA449367 | |||||||
| Human Metabolome Database | HMDB0015110 | |||||||
| DrugBank | DB00975 | |||||||
| PubChem: Thomson Pharma | 14811101 | |||||||
| PubChem | 3108 | |||||||
| Mcule | MCULE-3112669573 | |||||||
| NMRShiftDB | 20208396 | |||||||
| LINCS | LSM-3927 | |||||||
| Nikkaji | J8.585E | |||||||
| PDBe | H9F | |||||||
| BindingDB | 23620 | |||||||
| EPA CompTox Dashboard | DTXSID6040668 | |||||||
| DrugCentral | 924 | |||||||
| Brenda | 138816 | 229397 | 153397 | 69114 | 154381 | 70635 | 229398 | 1192 |
| ChemicalBook | CB6731869 | |||||||
| Guide to Pharmacology | 4807 | |||||||
| rxnorm | DIPYRIDAMOLE | PERSANTINE | ||||||
| PubChem: Drugs of the Future | 81044336 | |||||||
| ChEBI | 4653 | |||||||
| ZINC | ZINC000000643046 |
